ID: ALA2333256

Max Phase: Preclinical

Molecular Formula: C17H28N2OSSi2

Molecular Weight: 364.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(-c2nnc(CSC([Si](C)(C)C)[Si](C)(C)C)o2)cc1

Standard InChI:  InChI=1S/C17H28N2OSSi2/c1-13-8-10-14(11-9-13)16-19-18-15(20-16)12-21-17(22(2,3)4)23(5,6)7/h8-11,17H,12H2,1-7H3

Standard InChI Key:  CTLUFSWFXQTFHO-UHFFFAOYSA-N

Associated Targets(non-human)

RBL-2H3 1162 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.66Molecular Weight (Monoisotopic): 364.1461AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Guda DR, Park SJ, Lee MW, Kim TJ, Lee ME..  (2013)  Syntheses and anti-allergic activity of 2-((bis(trimethylsilyl)methylthio/methylsulfonyl)methyl)-5-aryl-1,3,4-oxadiazoles.,  62  [PMID:23353735] [10.1016/j.ejmech.2012.12.035]

Source